PhotoPharmics, an innovator in Parkinson’s disease research and treatment, today announced the successful first close of a $16 million investment round. The investment round, led by Kickstart Fund, a venture…

RIVANNA®, developers of world-first, imaging-based medical solutions, announced they received a $2.9 million grant from the National Institutes of Health (NIH). The grant will further the development of Accuro® 3S,…

Fire chiefs from Canada, Mexico, the United Kingdom, and the U.S. participated in the National Fire Protection Association® (NFPA®) Urban Fire Forum (UFF) last week at NFPA headquarters in Quincy, MA, endorsing five important…

ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket approval of its HYDRAFIL® System. The HYDRAFIL System…

Regenesis Biomedical, Inc., a medical devic­­e company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve).  Reprieve is the only home-use shortwave…

Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the…

Obvius Robotics, Inc., a medical device company that has developed an innovative technology platform for performing percutaneous access, today announced the successful completion of its first human cases.

Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval (PMA) application for its…

 BlueWind Medical, Ltd., the developer of a transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced results from the OASIS pivotal trial evaluating the safety and efficacy of…